Model Informed Drug Development Archives

Publication

Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator

The article "Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system…

CertaraAugust 26, 2024

Publication

Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)

The article “Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL)…

CertaraAugust 26, 2024

Video

Certara’s MIDD Oncology Capabilities

Improve Oncology Study Decisions with Certara's MIDD Team Transcript: The pace of oncology drug…

CertaraAugust 7, 2024

Publication

A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator

This collaborative effort by Certara and the Centre for Applied Pharmacokinetic Research (CAPKR) at The…

CertaraJuly 24, 2024

Conference

BioTechX EU

CertaraJuly 23, 2024

Publication

New Horizons of Model Informed Drug Development in Rare Diseases Drug Development

Model-informed drug development is revolutionizing the way we approach rare diseases, where traditional large-scale clinical…

CertaraJuly 11, 2024

Publication

A literature review of drug transport mechanisms during lactation

The literature review titled "A literature review of drug transport mechanisms during lactation," authored by…

CertaraJuly 7, 2024

Blog

Why Medical/Regulatory Writing Services Use Style Guides & Lexicons

Learn how style guides and lexicons help medical writers produce clear, consistent, and accurate content…

CertaraMarch 18, 2024

Publication

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…

CertaraFebruary 23, 2024

On-Demand Webinar

Off-Target Drug Safety: Replacing Educated Guesswork with Evidence-Based Risk Assessment

ToxStudio integrates safety and toxicology software to address three critical areas in preclinical safety: Cardiac…

CertaraDecember 19, 2023

Model Informed Drug Development

Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator

Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)

Certara’s MIDD Oncology Capabilities

A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator

BioTechX EU

New Horizons of Model Informed Drug Development in Rare Diseases Drug Development

A literature review of drug transport mechanisms during lactation

Why Medical/Regulatory Writing Services Use Style Guides & Lexicons

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

Off-Target Drug Safety: Replacing Educated Guesswork with Evidence-Based Risk Assessment

Newsletter sign up

Quick links

Solutions

Contact